BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.3769
-0.0155 (-3.95%)
Aug 14, 2025, 11:24 AM - Market open
BioAtla Market Cap
BioAtla has a market cap or net worth of $22.13 million as of August 14, 2025. Its market cap has decreased by -72.12% in one year.
Market Cap
22.13M
Enterprise Value
10.88M
1-Year Change
-72.12%
Ranking
Category
Stock Price
$0.38
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $577.60M to $22.13M, a decrease of -96.17%. That is a compound annual growth rate of -50.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 23.04M | -32.83% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -69.81% |
| Dec 30, 2022 | 390.66M | -45.97% |
| Dec 31, 2021 | 723.09M | -36.84% |
| Dec 31, 2020 | 1.14B | 98.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |